Persistent dyslipidemia in Chinese patients treated with lipid-lowering drugs: interim results of the dyslipidaemia international study (DYSIS) China

被引:0
|
作者
Hu, D. Y. [1 ]
Wang, Y. J. [2 ]
Zhao, S. P. [3 ]
Mu, Y. M. [4 ]
机构
[1] Peking Univ, Peoples Hosp, Beijing 100871, Peoples R China
[2] Capital Med Univ, Tiantan Hosp, Beijing, Peoples R China
[3] Cent S Univ, Xiangya Hosp 2, Dept Cardiol, Changsha, Hunan, Peoples R China
[4] China PLA Gen Hosp, Beijing, Peoples R China
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:797 / 797
页数:1
相关论文
共 50 条
  • [1] Prevalence of dyslipidaemia in patients treated with lipid-lowering agents in China: Results of the DYSlipidemia International Study (DYSIS)
    Zhao, Shuiping
    Wang, Yongjun
    Mu, Yiming
    Yu, Bilian
    Ye, Ping
    Yan, Xiaowei
    Li, Zhanquan
    Wei, Yidong
    Ambegaonakr, Baishaili M.
    Hu, Dayi
    ATHEROSCLEROSIS, 2014, 235 (02) : 463 - 469
  • [2] Persistent lipid abnormalities in patients treated with stains: Portuguese results of the Dyslipidemia International Study (DYSIS)
    Marques da Silva, P.
    Massano Cardoso, S.
    REVISTA PORTUGUESA DE CARDIOLOGIA, 2011, 30 (01) : 47 - 63
  • [3] Prevalence of persistent lipid abnormalities in statin-treated patients: Belgian results of the Dyslipidaemia International Study (DYSIS)
    Devroey, D.
    Radermecker, R. P.
    Van der Schueren, B. J.
    Torbeyns, B.
    Jaken, R. J.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2014, 68 (02) : 180 - 187
  • [4] Persistent lipid abnormalities in patients with hypertension and dyslipidemia treated with statins: results of the Portuguese hypertensive subpopulation of the Dyslipidemia International Study (DYSIS)
    Silva, Pedro M.
    Cardoso, Salvador M.
    Ferreira, Antonio M.
    CLINICAL AND EXPERIMENTAL HYPERTENSION, 2015, 37 (02) : 116 - 121
  • [5] Undertreatment of female patients in lipid-lowering for secondary prevention in Europe, Canada, South Africa, Middle East and China: results of the Dyslipidemia International Study (DYSIS)
    Gitt, A. K.
    Lautsch, D.
    Horack, M.
    Brudi, P. H.
    Poh, K. K.
    De Ferrari, G.
    Ferrieres, J.
    EUROPEAN HEART JOURNAL, 2017, 38 : 117 - 117
  • [6] Lipid-lowering therapy and lipid goal attainment in patients with metabolic syndrome in China: subgroup analysis of the Dyslipidemia International Study-China (DYSIS-China)
    Wang Fan
    Hu Dayi
    Zhao Shuiping
    Wang Yongjun
    Mu Yiming
    Yu Bilian
    Yan Xiaowei
    Li Zhanquan
    Wei Yidong
    Ambegaonakr, Baishali M.
    Min Yin
    Ping Ye
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (16) : C109 - C110
  • [7] Lipid-lowering therapy and lipid goal attainment in patients with metabolic syndrome in China: Subgroup analysis of the Dyslipidemia International Study-China (DYSIS-China)
    Wang, Fan
    Ye, Ping
    Hu, Dayi
    Min, Ying
    Zhao, Shuiping
    Wang, Yongjun
    Mu, Yiming
    Yan, Xiaowei
    Li, Zhanquan
    Wei, Yidong
    Li, Jihu
    ATHEROSCLEROSIS, 2014, 237 (01) : 99 - 105
  • [8] LDL-cholesterol goal attainment under persistent lipid-lowering therapy in northeast China Subgroup analysis of the dyslipidemia international study of China (DYSIS-China)
    Zheng, Wen
    Zhang, Yu-Jiao
    Bu, Xiang-Ting
    Guo, Xin-Zhu
    Hu, Da-Yi
    Li, Zhan-Quan
    Sun, Jian
    MEDICINE, 2017, 96 (46)
  • [9] UNDERTREATMENT OF FEMALE PATIENTS IN LIPID-LOWERING FOR SECONDARY PREVENTION IN EUROPE, CANADA, SOUTH-AFRICA, MIDDLE EAST AND CHINA: RESULTS OF THE DYSLIPIDEMIA INTERNATIONAL STUDY (DYSIS)
    Gitt, Anselm K.
    Lautsch, Dominik
    Horack, Martin
    Brudi, Philippe
    Liu, Larry
    Ferrieres, Jean
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 1748 - 1748
  • [10] Persistent lipid abnormalities in statin-treated patients: Portuguese diabetic subpopulation of the Dyslipidaemia International Study (DYSIS)
    da Silva, Pedro Marques
    Cardoso, Salvador Massano
    Ferreira, Antonio Miguel
    PRIMARY CARE DIABETES, 2015, 9 (04) : 283 - 289